Trial Profile
ARB+diurites vs ARB+Ca blocker.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 May 2015
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Amlodipine; Hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms TAT Kobe
- 27 May 2015 Status changed from recruiting to active, no longer recruiting as per University Hospital Medical Information Network - Japan record.
- 28 Apr 2011 New trial record